Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Continuity of Pharmacotherapy for Opioid Use Disorder

CBE ID
3175
Endorsement Status
Endorsed
1.0 New or Maintenance
Maintenance
1.1 Measure Structure
Single Measure
Previous Endorsement Cycle
Spring 2021
Is Under Review
No
Next Maintenance Cycle
Spring 2027
1.6 Measure Description

Percentage of adults of at least 18 years of age with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment

Measure Specs
General Information
1.7 Measure Type
Process
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
Clinician: Group/Practice
Clinician: Individual
Health Plan
1.20 Types of Data Sources
Claims Data
1.14 Numerator

Individuals in the denominator who have at least 180 days of continuous pharmacotherapy with a medication prescribed for OUD without a gap of more than seven days

1.15 Denominator

Individuals at least 18 years of age who had a diagnosis of OUD and at least one claim for an OUD medication

Exclusions

There are no denominator exclusions.

1.13 Data Dictionary
Not attached. I attest that all information will be provided where codes and/or value sets are needed (1.14a - 1.15c).
Most Recent Endorsement Activity
Endorsed Behavioral Health and Substance Use Spring Cycle 2021
Initial Endorsement
Last Updated
Steward Organization
University of Southern California
Steward POC email
[email protected]
Steward Organization Copyright

Some proprietary codes are contained in the measure specifications for convenience of the user. Use of these codes may require permission from the code owner or agreement to a license.

ICD-10 codes are copyrighted © World Health Organization (WHO), Fourth Edition, 2021. CPT © 2021 American Medical Association. CPT is a registered trademark of the American Medical Association. All rights reserved.

Risk Adjustment
No risk adjustment or risk stratification
Use
6.1.2 Current or Planned Use(s)
Payment Program
Regulatory and Accreditation Programs
6.1.3 Current or Planned Use(s)
Payment Program
Regulatory and Accreditation Programs
Public Comments